Asset Search and BD AnalyticsCase Study

Asset search for business development opportunities for a company seeking to expand its rare disease portfolio, focused on central nervous system diseases

The Situation

US-based pharmaceutical company, anticipating the launch of its new rare disease product, was seeking to add to its portfolio through licensing or acquisition opportunities

The Ask

Client sought to uncover compelling opportunities, profile attractive assets, and determine which assets were worthy of further analysis

The Actions

Secondary Research

Conducted extensive secondary research to build a database of asset opportunities, which were further prioritized by utilizing key product data, such as molecule’s mechanism of action, indications that were being pursued and the relevant preclinical and clinical data supporting development, insights into the treatment paradigm, unmet needs, and competitive landscape
Reached out to asset holders to further vet select opportunities and assess business development actionability

The Impact

PROFILED high interest opportunities, including a company overview, disease and patient population background, product highlights (mechanism of action, clinical data, points of differentiation), and fit with the client’s criteria

PROVIDED ideas the client had not found and offered new ways to consider opportunities the client might have previously disregarded, as well as a methodology to compare those opportunities to ones already on the client’s radar

Bluestar BioAdvisors, LLC

521 Fifth Avenue, 25th Floor
New York, NY USA 10175

(212) 257-6030